The rate of stroke or systemic embolism with rivaroxaban vs. warfarin was consistent among patients with SVD -LSB- @ vs. @ % ; hazard ratio ( HR ) @ , @ % confidence interval ( CI ) @-@ @ -RSB- and without SVD ( @ vs. @ % ; HR @ , @ % CI @-@ @ ; interaction P = @ ) .